Cerebral Blood Flow Predicts Recovery in Children with Persistent Post-Concussion Symptoms after Mild Traumatic Brain

Karen M Barlow1,2,3,4, Kartik Iyer1, Tingting Yan3

  • 1Children's Health Research Centre, University of Queensland, Brisbane, Queensland, Australia.

Journal of Neurotrauma
|January 12, 2021
PubMed

Insights

Cerebral blood flow (CBF) was higher in children with persistent post-concussion symptoms (PPCS) who showed poor recovery. Decreased CBF over time predicted better outcomes in pediatric mild traumatic brain injury (mTBI) patients.

Area of Science:

  • Neurology
  • Pediatric Medicine
  • Radiology

Background:

  • Persistent post-concussion symptoms (PPCS) following pediatric mild traumatic brain injury (mTBI) are linked to altered cerebral blood flow (CBF).
  • Understanding CBF changes during recovery is crucial for identifying therapeutic targets in pediatric mTBI.

Purpose of the Study:

  • To investigate CBF changes during recovery in children experiencing PPCS after mTBI.
  • To determine if CBF changes correlate with clinical recovery and can predict outcomes.

Main Methods:

  • A prospective cohort study involving 61 children and adolescents with PPCS.
  • Three-dimensional (3D) pseudo-continuous arterial spin-labelled (pCASL) MRI was used to assess CBF at two time points (4-6 and 8-10 weeks post-injury).
  • Participants were categorized based on clinical recovery status at the second scan.

Main Results:

  • Children with poor recovery exhibited higher relative and mean absolute CBF compared to those with good recovery.
  • CBF decreased over time, with a more significant decrease observed in participants who achieved good recovery.
  • The rate of CBF decrease predicted recovery outcome in 77% of children with PPCS.

Conclusions:

  • CBF dynamics during recovery are associated with clinical outcomes in pediatric mTBI.
  • A decrease in CBF over time may serve as a predictive biomarker for recovery in children with PPCS.
  • Further research is needed to validate CBF as a predictive biomarker for PPCS outcomes.